Cytolysins augment superantigen penetration of stratified mucosa

Journal of Immunology

Volumn 182, Issue 4, 2009, Pages 2364-2373

  Brosnahan, Amanda J ^a   Mantz, Mary J ^b   Squier, Christopher A ^b   Peterson, Marnie L ^c   Schlievert, Patrick M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOXIN; CYTOLYSIN; INTERLEUKIN 1BETA; PYROGENIC EXOTOXIN A; STREPTOLYSIN O; SUPERANTIGEN; TOXIC SHOCK SYNDROME TOXIN 1; UNCLASSIFIED DRUG; VIRULENCE FACTOR; BACTERIAL PROTEIN; BACTERIAL TOXIN; CYTOTOXIN; ENTEROTOXIN; ENTEROTOXIN F, STAPHYLOCOCCAL; EXOTOXIN; MEMBRANE PROTEIN; SPEA PROTEIN, STREPTOCOCCUS PYOGENES; STREPTOLYSIN;

ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; CYTOKINE RELEASE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE; TOXIC SHOCK SYNDROME; VAGINA MUCOSA; ANIMAL; EPITHELIUM CELL; FEMALE; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MUCOSA; RABBIT; SEPTIC SHOCK; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; SWINE; VAGINA;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CYTOTOXINS; ENTEROTOXINS; EPITHELIAL CELLS; EXOTOXINS; FEMALE; HUMANS; MEMBRANE PROTEINS; MUCOUS MEMBRANE; RABBITS; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOLYSINS; SUPERANTIGENS; SWINE; VAGINA;

EID: 61449090444     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803283     Document Type: Article

References (80)

1. Cone, L. A., D. R. Woodard, P. M. Schlievert, and G. S. Tomory. 1987. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N. Engl. J. Med. 317: 146-149.
2. Todd, J., M. Fishaut, F. Kapral, and T. Welch. 1978. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 2: 1116-1118.
3. Davis, J. P., P. J. Chesney, P. J. Wand, and M. LaVenture. 1980. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N. Engl. J. Med. 303: 1429-1435.
4. Shands, K. N., G. P. Schmid, B. B. Dan, D. Blum, R. J. Guidotti, N. T. Hargrett, R. L. Anderson, D. L. Hill, C. V. Broome, J. D. Band, and D. W. Fraser. 1980. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N. Engl. J. Med. 303: 1436-1442.
5. Kotb, M., A. Norrby-Teglund, A. McGeer, H. El-Sherbini, M. T. Dorak, A. Khurshid, K. Green, J. Peeples, J. Wade, G. Thomson, B. Schwartz, and D. E. Low. 2002. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat. Med. 8: 1398-1404.
6. Stevens, D. L., M. H. Tanner, J. Winship, R. Swarts, K. M. Ries, P. M. Schlievert, and E. Kaplan. 1989. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321: 1-7.
7. McCormick, J. K., M. L. Peterson, and P. M. Schlievert. 2006. Toxins and superantigens of group A streptococci. In Gram Positive Pathogens, 2nd Ed. R. P. Novick, V. A. Fischetti, J. J. Ferretti, D. A. Portnoy, and J. I. Rood, eds. ASM Press, Washington, D.C., pp. 47-58.
8. Schlievert, P. M., K. M. Bettin, and D. W. Watson. 1979. Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin. Infect. Immun. 26: 467-472.
9. Stevens, D. L. 2000. Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu. Rev. Med. 51: 271-288.
10. Kravitz, G. R., D. J. Dries, M. L. Peterson, and P. M. Schlievert. 2005. Purpura fulminans due to Staphylococcus aureus. Clin. Infect. Dis. 40: 941-947.
11. Centers for Disease Control and Prevention.1999. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus, Minnesota and North Dakota, 1997-1999. J. Am. Med. Assoc. 282: 1123-1125.
12. Schlievert, P. M., A. P. Assimacopoulos, and P. P. Cleary. 1996. Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. J. Lab. Clin. Med. 127: 13-22.
13. Reichardt, W., H. Muller-Alouf, J. E. Alouf, and W. Kohler. 1992. Erythrogenic toxins A, B and C: occurrence of the genes and exotoxin formation from clinical Streptococcus pyogenes strains associated with streptococcal toxic shock-like syndrome. FEMS Microb. Lett. 79: 313-322.
14. Hauser, A. R., D. L. Stevens, E. L. Kaplan, and P. M. Schlievert. 1991. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J. Clin. Microbiol. 29: 1562-1567.
15. Musser, J. M., A. R. Hauser, M. H. Kim, P. M. Schlievert, K. Nelson, and R. K. Selander. 1991. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc. Natl. Acad. Sci. USA 88: 2668-2672.
16. Lee, P. K., and P. M. Schlievert. 1989. Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndromelike illness. J. Clin. Microbiol. 27: 1890-1892.
17. Talkington, D. F., B. Schwartz, C. M. Black, J. K. Todd, J. Elliott, R. F. Breiman, and R. R. Facklam. 1993. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect. Immun. 61: 3369-3374.
18. Bergdoll, M. S. 1988. Monkey feeding test for staphylococcal enterotoxin. Methods Enzymol. 165: 324-333.
19. Schlievert, P. M. 1986. Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1: 1149-1150.
20. Schlievert, P. M., T. J. Tripp, and M. L. Peterson. 2004. Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period. J. Clin. Microbiol. 42: 2875-2876.
21. Bergdoll, M. S., B. A. Crass, R. F. Reiser, R. N. Robbins, and J. P. Davis. 1981. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1: 1017-1021.
22. Schlievert, P. M., K. N. Shands, B. B. Dan, G. P. Schmid, and R. D. Nishimura. 1981. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J. Infect. Dis. 143: 509-516.
23. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248: 1066.
24. Choi, Y., J. A. Lafferty, J. R. Clements, J. K. Todd, E. W. Gelfand, J. Kappler, P. Marrack, and B. L. Kotzin. 1990. Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J. Exp. Med. 172: 981-984.
25. Fraser, J. D. 1989. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. 339: 221-223.
26. Scholl, P., A. Diez, and R. Geha. 1989. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules. J. Immunol. 143: 2583-2588.
27. White, J., A. Herman, A. M. Pullen, R. Kubo, J. W. Kappler, and P. Marrack. 1989. The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56: 27-35.
28. Callahan, J. E., A. Herman, J. W. Kappler, and P. Marrack. 1990. Stimulation of B10.BR T cells with superantigenic staphylococcal toxins. J. Immunol. 144: 2473-2479.
29. Schlievert, P. M., K. M. Bettin, and D. W. Watson. 1978. Effect of antipyretics on group A streptococcal pyrogenic exotoxin fever production and ability to enhance lethal endotoxin shock. Proc. Soc. Exp. Biol. Med. 157: 472-475.
30. Dinges, M. M., J. Jessurun, and P. M. Schlievert. 1998. Comparisons of mouse and rabbit models of toxic shock syndrome. Int. Congr. Symp. Ser. 229: 167-168.
31. Dinges, M. M., and P. M. Schlievert. 2001. Comparative analysis of lipopolysaccharide-induced tumor necrosis factor α activity in serum and lethality in mice and rabbits pretreated with the staphylococcal superantigen toxic shock syndrome toxin 1. Infect. Immun. 69: 7169-7172.
32. Schlievert, P. M., and D. W. Watson. 1979. Biogenic amine involvement in pyrogenicity and enhancement of lethal endotoxin shock by group A streptococcal pyrogenic exotoxin. Proc. Soc. Exp. Biol. Med. 162: 269-274.
33. Kotzin, B. L., D. Y. Leung, J. Kappler, and P. Marrack. 1993. Superantigens and their potential role in human disease. Adv. Immunol. 54: 99-166.
34. Squier, C. A., M. J. Mantz, P. M. Schlievert, and C. C. Davis. 2008. Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa. J. Pharm. Sci. 97: 9-21.
35. Schlievert, P. M., M. Y. Kotb, and D. L. Stevens. 2000. Streptococcal superantigens: streptococcal toxic shock syndrome. In Effects of Microbes on the Immune System. M. W. Cunningham and R. S. Fujinami, eds. Lippincott Williams & Wilkins, Philadelphia, pp. 25-39.
36. Schlievert, P. M., L. M. Jablonski, M. Roggiani, I. Sadler, S. Callantine, D. T. Mitchell, D. H. Ohlendorf, and G. A. Bohach. 2000. Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals. Infect. Immun. 68: 3630-3634.
37. Eschenbach, D. A., S. S. Thwin, D. L. Patton, T. M. Hooton, A. E. Stapleton, K. Agnew, C. Winter, A. Meier, and W. E. Stamm. 2000. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin. Infect. Dis. 30: 901-907.
38. Law, S., P. W. Wertz, D. C. Swartzendruber, and C. A. Squier. 1995. Regional variation in content, composition and organization of porcine epithelial barrier lipids revealed by thin-layer chromatography and transmission electron microscopy. Arch. Oral Biol. 40: 1085-1091.
39. Patton, D. L., S. S. Thwin, A. Meier, T. M. Hooton, A. E. Stapleton, and D. A. Eschenbach. 2000. Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am. J. Obstet. Gynecol. 183: 967-973.
40. Squier, C. A., and M. J. Kremer. 2001. Biology of oral mucosa and esophagus. J. Natl. Cancer Inst. Monogr. 7-15.
41. van der Bijl, P., I. O. Thompson, and C. A. Squier. 1997. Comparative permeability of human vaginal and buccal mucosa to water. Eur. J. Oral Sci. 105: 571-575.
42. Wertz, P. W., and B. van den Bergh. 1998. The physical, chemical and functional properties of lipids in the skin and other biological barriers. Chem. Phys. Lipids 91: 85-96.
43. Thompson, I. O., P. van der Bijl, C. W. van Wyk, and A. D. van Eyk. 2001. A comparative light-microscopic, electron-microscopic and chemical study of human vaginal and buccal epithelium. Arch. Oral Biol. 46: 1091-1098.
44. Davis, C. C., M. J. Kremer, P. M. Schlievert, and C. A. Squier. 2003. Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution, and tissue damage. Am. J. Obstet. Gynecol. 189: 1785-1791.
45. Peterson, M. L., K. Ault, M. J. Kremer, A. J. Klingelhutz, C. C. Davis, C. A. Squier, and P. M. Schlievert. 2005. The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1. Infect. Immun. 73: 2164-2174.
46. Palmer, M. 2001. The family of thiol-activated, cholesterol-binding cytolysins. Toxicon 39: 1681-1689.
47. Bhakdi, S., J. Tranum-Jensen, and A. Sziegoleit. 1985. Mechanism of membrane damage by streptolysin-O. Infect. Immun. 47: 52-60.
48. Palmer, M. 2004. Cholesterol and the activity of bacterial toxins. FEMS Microb. Lett. 238: 281-289.
49. Song, L., M. R. Hobaugh, C. Shustak, S. Cheley, H. Bayley, and J. E. Gouaux. 1996. Structure of staphylococcal α-hemolysin, a heptameric transmembrane pore. Science 274: 1859-1866.
50. Dragneva, Y., C. D. Anuradha, A. Valeva, A. Hoffmann, S. Bhakdi, and M. Husmann. 2001. Subcytocidal attack by staphylococcal α toxin activates NF-κB and induces interleukin-8 production. Infect. Immun. 69: 2630-2635.
51. Ruiz, N., B. Wang, A. Pentland, and M. Caparon. 1998. Streptolysin O and adherence synergistically modulate proinflammatory responses of keratinocytes to group A streptococci. Mol. Microbiol. 27: 337-346.
52. Walev, I., M. Hombach, W. Bobkiewicz, D. Fenske, S. Bhakdi, and M. Husmann. 2002. Resealing of large transmembrane pores produced by streptolysin O in nucleated cells is accompanied by NF-κB activation and downstream events. FASEB J. 16: 237-239.
53. Kushnaryov, V. M., H. S. MacDonald, R. F. Reiser, and M. S. Bergdoll. 1989. Reaction of toxic shock syndrome toxin 1 with endothelium of human umbilical cord vein. Rev Infect. Dis. 11(Suppl 1): S282-S287; discussion S287-S288.
54. Kushnaryov, V. M., M. S. Bergdoll, H. S. MacDonald, J. Vellinga, and R. Reiser. 1984. Study of staphylococcal toxic shock syndrome toxin in human epithelial cell culture. J. Infect. Dis. 150: 535-545.
55. Kushnaryov, V. M., H. S. MacDonald, R. Reiser, and M. S. Bergdoll. 1984. Staphylococcal toxic shock toxin specifically binds to cultured human epithelial cells and is rapidly internalized. Infect. Immun. 45: 566-571.
56. Lee, P. K., G. M. Vercellotti, J. R. Deringer, and P. M. Schlievert. 1991. Effects of staphylococcal toxic shock syndrome toxin 1 on aortic endothelial cells. J. Infect. Dis. 164: 711-719.
57. Aubert, V., D. Schneeberger, A. Sauty, J. Winter, P. Sperisen, J. D. Aubert, and F. Spertini. 2000. Induction of tumor necrosis factor α and interleukin-8 gene expression in bronchial epithelial cells by toxic shock syndrome toxin 1. Infect. Immun. 68: 120-124.
58. Yang, P. C., T. Liu, C. S. Wang, N. Z. Zhang, and Z. D. Tao. 2000. Active ion secretion and permeability of rabbit maxillary sinus epithelium, impact of staphylococcal enterotoxin B. Otolaryngol Head Neck Surg. 123: 120-123.
59. O'Brien, G. J., G. Riddell, J. S. Elborn, M. Ennis, and G. Skibinski. 2006. Staphylococcus aureus enterotoxins induce IL-8 secretion by human nasal epithelial cells. Respir. Res. 7: 115.
60. Herz, U., R. Ruckert, K. Wollenhaupt, T. Tschernig, U. Neuhaus-Steinmetz, R. Pabst, and H. Renz. 1999. Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness: a model for non-allergic asthma. Eur. J. Immunol. 29: 1021-1031.
61. Rajagopalan, G., M. K. Smart, R. Patel, and C. S. David. 2006. Acute systemic immune activation following conjunctival exposure to staphylococcal enterotoxin B. Infect. Immun. 74: 6016-6019.
62. Rajagopalan, G., M. K. Smart, N. Murali, R. Patel, and C. S. David. 2007. Acute systemic immune activation following vaginal exposure to staphylococcal enterotoxin B: implications for menstrual shock. J. Reprod. Immunol. 73: 51-59.
63. Rajagopalan, G., M. M. Sen, M. Singh, N. S. Murali, K. A. Nath, K. Iijima, H. Kita, A. A. Leontovich, U. Gopinathan, R. Patel, and C. S. David. 2006. Intranasal exposure to staphylococcal enterotoxin B elicits an acute systemic inflammatory response. Shock 25: 647-656.
64. Rajagopalan, G., K. Iijima, M. Singh, H. Kita, R. Patel, and C. S. David. 2006. Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect. Immun. 74: 1284-1296.
65. Schlievert, P. M. 1982. Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect. Immun. 36: 123-128.
66. Wannamaker, L. W., and P. M. Schlievert 1988. Exotoxins of group A streptococci. In Handbook of Natural Toxins: Bacterial Toxins, Vol. 4. M. C. Hardegree and A. T. Tu, eds. Marcel Dekker, New York, pp. 267-295.
67. Kreiswirth, B. N., J. P. Handley, P. M. Schlievert, and R. P. Novick. 1987. Cloning and expression of streptococcal pyrogenic exotoxin A and staphylococcal toxic shock syndrome toxin-1 in Bacillus subtilis. Mol. Gen. Genet. 208: 84-87.
68. Nauciel, C., J. Blass, R. Mangalo, and M. Raynaud. 1969. Evidence for two molecular forms of streptococcal erythrogenic toxin: conversion to a single form by 2-mercaptoethanol. Eur. J. Biochem. 11: 160-164.
69. Schlievert, P. M. 1988. Immunochemical assays for toxic shock syndrome toxin-1. Methods Enzymol. 165: 339-344.
70. Bhakdi, S., and J. Tranum-Jensen. 1991. α toxin of Staphylococcus aureus. Microbiol. Rev. 55: 733-751.
71. Halbert, C. L., G. W. Demers, and D. A. Galloway. 1992. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol. 66: 2125-2134.
72. Kiyono, T., S. A. Foster, J. I. Koop, J. K. McDougall, D. A. Galloway, and A. J. Klingelhutz. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396: 84-88.
73. Giantonio, B. J., R. K. Alpaugh, J. Schultz, C. McAleer, D. W. Newton, B. Shannon, Y. Guedez, M. Kotb, L. Vitek, R. Persson, et al. 1997. Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer. J. Clin. Oncol. 15: 1994-2007.
74. Shi, Y., J. E. Evans, and K. L. Rock. 2003. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521.
75. Nyberg, S. L., P. M. Schlievert, W. Saul, J. R. Johnson, P. Ferrieri, and V. S. Watkins. 1995. Successful management of a serious group A streptococcal infection during the third trimester of pregnancy. Clin. Infect. Dis. 21: 1058-1059.
76. Squier, C. A., M. J. Kremer, A. Bruskin, A. Rose, and J. D. Haley. 1999. Oral mucosal permeability and stability of transforming growth factor β-3 in vitro. Pharm. Res. 16: 1557-1563.
77. Ceciliani, F., A. Giordano, and V. Spagnolo. 2002. The systemic reaction during inflammation: the acute-phase proteins. Protein Pept. Lett. 9: 211-223.
78. Schutyser, E., S. Struyf, and J. Van Damme. 2003. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14: 409-426.
79. Bromley, S. K., T. R. Mempel, and A. D. Luster. 2008. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 9: 970-980.
80. th General Meeting Abstracts Book, June 1-5, Boston, MA, pp. 62-63. ASM Press, Herndon, VA.